PolyPid Ltd. (PYPD)

NASDAQ: PYPD · USD

$5.73

-0.04 (-0.7%)· Recorded snapshot

Market cap	116.4M
Net income (ttm)	-31.5M
EPS (ttm)	-$1.48
Shares out	20.3M
Volume	130,905
Beta	1.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -31.5M
EPS (ttm): -$1.48
Market cap: 116.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-243.6

P25 n/aP50 n/aP75 n/a

ROIC-109.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PYPD indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001611842
Company name	PolyPid Ltd.
Country	Israel
Country code	US
CUSIP number	M8001Q126
Earnings date	2026-11-11
Earnings time	bmo
Employees	75
Employees change	14
Employees growth	22.95%
Enterprise value	$111.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
Industry	Biotechnology
IPO date	2020-06-26
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0011326795
Last 10-K release date	2026-02-25
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2023-09-21
Last stock split type	Reverse
Market cap	$116.4M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$5.73
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PYPD
Website	https://www.polypid.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-25.76%
FCF / EV yield	-26.21%
FCF yield	-25.09%
Forward EV/Sales	6.14x
Forward P/S	6.41x
P/B ratio	21.75x
Price / tangible book value	21.75x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-420,013
ROA	-74.63%
ROA (5Y)	-71.26%
ROCE	-366.05%
ROE	-243.59%
ROE (5Y)	-590.26%
ROIC	-109.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-402,000
Depreciation and amortization	$1.5M
EBIT	$-31.6M
EBITDA	$-30.1M
EPS	$-1.48
FCF per share	$-1.45
Financing cash flow	$6.4M
Free cash flow	$-29.4M
Free cash flow minus SBC	$-32.8M
Income taxes	$-53,000
Investing cash flow	$11.6M
Net borrowing	$-5.8M
Net cash flow	$-10.9M
Net income	$-31.5M
Operating cash flow minus SBC	$-32.4M
Operating income	$-31.6M
Stock-based compensation	$3.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.27
Debt / equity	0.29
Interest coverage	-168.95
Long-term assets	$6.3M
Long-term liabilities	$3.2M
Net cash (debt)	$5M
Net cash / market cap	4.26%
Net cash growth	-75.99%
Net debt / equity	-0.93
Piotroski F-Score	1
Property, plant and equipment	$6M
Shareholders' equity	$5.4M
Tangible book value	$5.4M
Tangible book value per share	$0.27
Total assets	$15.2M
Total cash	$6.6M
Total debt	$1.6M
Total liabilities	$9.8M
WACC	11.8%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$8.9M
Current liabilities	$6.6M
Current ratio	1.35
Net working capital	$-3M
Quick ratio	0.99
Working capital	$2.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-121.57%
Dividend yield	0%
Shareholder yield	-121.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$4.82
1D price change	-0.69%
1M price change	9.77%
1M total return	9.77%
1W price change	11.26%
1W total return	11.26%
1Y price change	58.73%
1Y return CAGR	58.78%
1Y total return	58.73%
20-day SMA	$5.12
200-day SMA	$4.72
3M price change	43.97%
3M total return	43.97%
3Y price change	51.59%
3Y return CAGR	14.87%
3Y total return	51.59%
50-day SMA	$5.17
50-day SMA vs 200-day SMA	50over200
52-week high	$5.80
52-week high date	2026-10-28
52-week low	$3.50
52-week low date	2025-11-21
5Y price change	-97.37%
5Y return CAGR	-51.7%
5Y total return	-97.37%
6M price change	25.11%
6M total return	25.11%
All-time high	$583.50
All-time high date	2020-06-29
All-time low	$2.30
All-time low date	2025-04-07
Average true range (ATR)	$0.27
Average volume	119K
Beta (1Y)	1.33
Beta (2Y)	0.78
Beta (5Y)	1.38
Change from 52-week high	-1.21%
Change from 52-week low	63.71%
Change from all-time high	-99.02%
Change from all-time low	149.13%
Change from open	1.06%
Day's gap	-1.73%
Dollar volume	$750,086
High price	$5.80
Low price	$5.65
Monthly RSI	34.12
Open price	$5.67
Position in 52-week range	53.33%
Premarket change	-0.52%
Premarket close	$5.77
Premarket price	$5.74
Premarket volume	9.1K
Previous close	$5.77
Price vs 150-day SMA	18.95%
Price vs 20-day SMA	11.87%
Price vs 200-day SMA	21.5%
Price vs 50-day SMA	10.81%
Relative volume	1.1
Return from IPO open	-98.8%
Return from IPO price	-63.94%
RSI	66.47
Sharpe ratio	1.05
Sharpe ratio (3Y)	0.29
Sharpe ratio (5Y)	-0.4
Sortino ratio	1.57
Sortino ratio (3Y)	0.54
Sortino ratio (5Y)	-0.5
Volume	130.9K
Weekly RSI	62.03
YTD price change	32.03%
YTD total return	32.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12.2M
Float percentage	59.88%
Shares change (QoQ)	3.25%
Shares change (YoY)	121.57%
Shares held by insiders	7.42%
Shares held by institutions	12.06%
Shares outstanding	20.3M
Short % of float	1.04%
Short % of shares	0.62%
Short ratio	1.4 days

Deeper analysis on PYPD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PYPD report

Is a complete PYPD research report available?

No complete published report is available for PolyPid Ltd. (PYPD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

PolyPid Ltd. (PYPD)

Price

Financial snapshot

Fair-value bridge

Latest news · PYPD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PYPD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PYPD

Frequently asked questions